LRP1B and ovarian serous adenocarcinoma: Down-regulation of LRP1B was reported to promote cell growth and migration in colon cancer cells 35, and in renal cell cancer 36, and is associated with acquired chemotherapy resistance in high-grade serous ovarian cancer 37.